In a multicenter trial, 778 patients with septic shock who were being treated with catecholamine vasopressors were randomly assigned to either norepinephrine or vasopressin in addition to open-label vasopressors. There was no significant difference between the two groups in mortality at either 28 or 90 days, nor was there any significant difference in the rate of adverse events.
More...